BFM
MIST icon

Boothbay Fund Management’s Milestone Pharmaceuticals MIST Stock Holding History

Boothbay Fund Management’s Portfolio MIST Stock Details MIST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-24,700
Closed -$227K – 2269
2022
Q3 		$227K Sell
24,700
-2,600
-10% -$19.7K 0.01% 1733
2022
Q2 		$168K Buy
+27,300
New +$168K ﹤0.01% 1827

Other funds holding MIST

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return

Boothbay Fund Management's MIST Position: Q1 2026 in Review

Boothbay Fund Management opened a new position in Milestone Pharmaceuticals (MIST) in Q1 2026: 168,675 shares worth $201K. The stake represents ﹤0.01% of the portfolio and ranks #1780 among its holdings. This is a return to the name: Boothbay Fund Management previously reported a position in MIST as recently as Q4 2024.

Boothbay Fund Management first reported a position in MIST in Q2 2020 and has held it in 20 quarters since. The position peaked at $1.46M in Q3 2020. 86 funds tracked by Wall St. Rank hold MIST as of Q1 2026.

  • Boothbay Fund Management held 168,675 shares of Milestone Pharmaceuticals worth $201K as of Q1 2026.
  • Milestone Pharmaceuticals was a new Boothbay Fund Management position in Q1 2026.
  • Milestone Pharmaceuticals made up ﹤0.01% of Boothbay Fund Management's portfolio in Q1 2026, its #1780 holding.
  • Boothbay Fund Management first reported a position in Milestone Pharmaceuticals in Q2 2020 and has held it in 20 quarters since.
  • Boothbay Fund Management's Milestone Pharmaceuticals position peaked at $1.46M in Q3 2020.
  • 86 funds tracked by Wall St. Rank held Milestone Pharmaceuticals as of Q1 2026.

Based on Boothbay Fund Management's 13F filing for Q1 2026, filed 15 May 2026.